JAK inhibitor PF-06700841 P-Tosylate, Purity ≥98%

Synonym: PF-06700841 tosylate; 2140301-96-6; Brepocitinib (P-Tosylate); PF-06700841 (P-Tosylate); [(1S)-2,2-Difluorocyclopropyl]-[3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone; 4-methylbenzenesulfonic acid; Brepocitinib P-Tosylate; JAK inhibitor

CAS Number: 2140301-96-6
Compound CID: 135087197

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

PF-06700841 P-Tosylate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and JAK3.

Molecular Weight

561.6

Molecular Formula

C₂₅H₂₉F₂N₇O₄S

Targets

JAK1: 17 nM; JAK2: 77 nM; JAK3: 6.9 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

PF-06700841 P-Tosylate can be researched for selective inhibition of TYK2 and JAK1.

Storage

Store at -20ºC.